COVID-19 vaccines: The status and perspectives in delivery points of view
Due to the high prevalence and long incubation periods often without symptoms, the severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected millions of individuals …
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected millions of individuals …
[HTML][HTML] Immune response in COVID-19: A review
The immune system protects us from viruses and diseases. It produces an antibody to kill
pathogen. This review shows a brief picture about the immune system to protect us from …
pathogen. This review shows a brief picture about the immune system to protect us from …
Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
Objective To investigate the effectiveness of using convalescent plasma to treat moderate
coronavirus disease 2019 (covid-19) in adults in India. Design Open label, parallel arm …
coronavirus disease 2019 (covid-19) in adults in India. Design Open label, parallel arm …
Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is a new human disease with few effective …
syndrome coronavirus 2 (SARS-CoV-2), is a new human disease with few effective …
Potential therapeutic options for COVID-19: an update on current evidence
Abstract SARS-CoV-2, a novel coronavirus, is the agent responsible for the COVID-19
pandemic and is a major public health concern nowadays. The rapid and global spread of …
pandemic and is a major public health concern nowadays. The rapid and global spread of …
COVID‐19–associated Guillain‐Barré syndrome: The early pandemic experience
JB Caress, RJ Castoro, Z Simmons, SN Scelsa… - Muscle & …, 2020 - Wiley Online Library
Guillain‐Barré syndrome (GBS) is an inflammatory polyradiculoneuropathy associated with
numerous viral infections. Recently, there have been many case reports describing the …
numerous viral infections. Recently, there have been many case reports describing the …
Pharmaco-immunomodulatory therapy in COVID-19
The severe acute respiratory syndrome coronavirus 2 associated coronavirus disease 2019
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …
Role of inflammatory cytokines in COVID-19 patients: A review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to …
AA Rabaan, SH Al-Ahmed, J Muhammad, A Khan… - Vaccines, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is a severe pandemic of the current century. The vicious …
coronavirus 2 (SARS-CoV-2), is a severe pandemic of the current century. The vicious …
Wuhan to world: the COVID-19 pandemic
COVID-19 is a Severe Acute Respiratory Syndrome (SARS), caused by SARS-CoV-2, a
novel virus which belongs to the family Coronaviridae. It was first reported in December …
novel virus which belongs to the family Coronaviridae. It was first reported in December …
Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19
MA Thompson, JP Henderson, PK Shah… - JAMA …, 2021 - jamanetwork.com
Importance COVID-19 is a life-threatening illness for many patients. Prior studies have
established hematologic cancers as a risk factor associated with particularly poor outcomes …
established hematologic cancers as a risk factor associated with particularly poor outcomes …